Stem Cell Assay Market – Overview
Stem cells have a remarkable potential to develop into different types of cells and are involved in the internal repair system of the body. Stem cell assays are the techniques for analyzing the living cells on the parameters of shape, size, besides others with the aim to measure biochemical and cellular functioning of the cells. Such properties make the stem cell assays to be extensively utilized in industrial practices of drug development. Growing biotechnology sector and increasing global burden of diseases like cancer, diabetes, and others are estimated to be the major drivers for the market growth during the forecast period. According to the World Health Organization in 2017, the number of patients suffering from diabetes was estimated to be about 422 million in 2014. Moreover, WHO projected that by 2030, diabetes would be the seventh leading cause of death across the globe. Additionally, growing healthcare expenditure and rising government support boosts the market growth during the forecast period. However, factors such as stringent government policies, high procedural cost followed by lack of awareness and skilled forces will restrain the market growth during the projected period, 2017-2023. Market for Global Stem Cell Assay is Estimated to grow at an Approximate cagr of 19.80% from 2017 to 2023.
Get Sample Report with Current Market Trend here https://www.marketresearchfuture.com/sample_request/5656
Stem Cell Assay Market – Top Players
- GE Healthcare (U.K.)
- Promega Corporation (U.S.)
- Thermo Fisher Scientific (U.S.)
- Merck KGaA (Germany)
- Cell Biolabs, Inc. (U.S.)
- Hemogenix (U.S.)
- STEMCELL Technologies Inc. (CA)
- Bio-Rad Laboratories, Inc. (U.S.)
- Bio-Techne Corporation (U.S.)
- Cellular Dynamics International Inc. (U.S.), and others.
Global Stem Cell Assay Market – Regional Analysis
The Americas hold the largest share of global stem cell assay market. Increasing adoption of new technologies, huge patient population for diseases like diabetes, cancer and others, rising healthcare expenditure drives the market growth within the region. Europe stands second in the market. This can be attributed to the growing biotechnology sector, huge patient population, and increasing support by the government for research and development. Asia Pacific region is projected to be the fastest growing market for stem cell assay. Factors such as increasing awareness, rising healthcare expenditures, presence of the developing economies like India and China provide a favorable background for the growth of the market within the region. On the other hand, the Middle East & Africa holds the least share of the global stem cell assay market. Low per capita healthcare expenditure, lack of awareness, stringent government policies, and presence of poor economies, especially in the African region restraints the market growth within the region. A majority of the stem cell assay market within the region is held by the Middle East owing to a well-developed healthcare sector and huge healthcare expenditure in the developed economies like Saudi Arabia, Kuwait, and Qatar.
Avail Stunning Discount on Customize Reports – https://www.marketresearchfuture.com/check-discount/5656
Global Stem Cell Assay Market – Segmentation
The global stem cell assay market is segmented on the basis of product, technology, assay, application, and end-user. On the basis of the product, the market is categorized into micro electrode arrays, flow cytometer, cell imaging systems, automated cell counter, kits, and others. The kits segment is sub segmented into mesenchymal stem cell kits, induced pluripotent stem cell kits, umbilical cord stem cells, and others. On the basis of the technology, the market is segmented into micro fabricated assisted technology microfluidics based cell trap technologies, and others. On the basis of the assay, the market is segmented into cell viability & toxicity assays, cell identification assays, cell proliferation assays, cell apoptosis assays, and others. On the basis of the application, the market is segmented into orthopedic & musculoskeletal spine, dermatology, cardiovascular, central nervous system, and others. On the basis of the end user, the market is segmented into biotechnology industries, research organizations, academic institutes, and others.
Some of the Major Table Of Content
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Get Full TOC of the Report Here https://www.marketresearchfuture.com/enquiry/5656
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com